Percentage of female patients, age >18 at diagnosis, who have their first diagnosis of breast cancer (epithelial malignancy), at AJCC Stage T1cN0M0 (tumor greater than 1cm), or Stage 1B-III, whose primary tumor is progesterone and estrogen receptor negative recommended for multi-agent chemotherapy (recommended or administered) within 4 months (120 days) of diagnosis